Global Mycoplasma Testing Market Analysis, Drivers, Restraints, Opportunities, Threats, Trends, Applications, and Growth Forecast to 2027
MarketResearch.Biz delivers in-depth insights in its report titled, “Global Mycoplasma Testing Market Trends, Applications, Analysis, Growth, and Forecast to 2027". The global mycoplasma testing market is estimated to register a value X.X% CAGR during the forecast period. The report offers in-depth insights, revenue details, and other vital information regarding the global mycoplasma testing market, including the various trends, drivers, restraints, opportunities, and threats till 2027. The report offers insightful and detailed information regarding the various key players operating in the global market, and their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, market footprint, and opportunities. The mycoplasma testing market report has been segmented on the basis of product type, technique, application, end-user, and region.
Mycoplasma is a prokaryotic organism and a frequent occult contaminant of cell cultures. Without a cell wall around the cell membrane, they are unaffected by many common antibiotics such as penicillin or other beta-lactam antibiotics that target cell wall synthesis. This species of organism are the smallest bacterial cells yet discovered and can survive without oxygen, and come in various shapes.
Mycoplasma contamination is relatively common and can persist for a long time while remaining undetected. Mycoplasma contamination also adversely affects the research work of scientists in laboratories. Since this organism can modify many aspects of cell physiology, experiments that are conducted with previously contaminated cells become useless. Because of their small size, Mycoplasmas can pass through filters used to prevent bacterial and fungal contamination and potentially spread to all the cultures in a laboratory. Mycoplasma contamination can also occur through workers who are infected with M. orale or M. fermentans. Thus, it is essential that all new cell cultures entering a laboratory and all cell banks are tested for the presence of mycoplasma in order to generate robust data in the field of biomedical research.
Mycoplasma testing is carried out in the research and production of all biopharmaceutical products. Growth in the pharmaceutical and biotechnology sector across the globe serves as a direct driver for associated markets such as mycoplasma testing. Moreover, increasing healthcare spending in developing countries and growth in pharmaceutical outsourcing is creating opportunities for growth of the global mycoplasma testing market. However, some factors restraining market growth are stringent government regulations and high cost associated with mycoplasma testing.
The global mycoplasma testing market is dominated by North America, and the trend is expected to continue during the forecast period, followed by Europe. However, Asia Pacific is expected to witness highest revenue CAGR expansion, with majority of revenue coming from markets in China, Japan, and India due to growing government investments in pharmaceutical R&D and the increasing trend of pharmaceutical outsourcing.
Global Mycoplasma Testing Market Segmentation:
Global Mycoplasma Testing Market, by Product
- Kits & Reagents
- PCR Assay
- Nucleic Acid Detection
- Elimination Kits & Reagents
- Standards & Controls
- Other Kits & Reagents
Global Mycoplasma Testing Market, by Technique
- Direct Assay
- Indirect Assay
- DNA Staining
- Microbial Culture Techniques
- Enzymatic Methods
Global Mycoplasma Testing Market, by Application
- Cell Line Testing
- Virus Testing
- End of Production Cells Testing
- Other Applications
Global Mycoplasma Testing Market, by End Users
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Contract Research Organizations (CROs)
- Cell Banks
- Other End Users
Global Mycoplasma Testing Market, by Region
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
Particular Scope Region
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- Latin America
- Rest of Latin America
- Middle East and Africa
- South Africa
- Rest of Middle East and Africa
Estimated Year 2020 Actual Year 2021 Forecast Period 2021–2030 Revenue in US$
- Thermo Fisher Scientific Inc.
- Charles River Laboratories International Inc.
- Lonza Group Ltd.
- Merck KGaA
- Roche Diagnostics
- SGS S.A.
- American Type Culture Collection
- Bionique Testing Laboratories Inc.
- PromoCell GmbH
Request for TOC
Request for Customization
Don't just take our word. We are trusted by these great companies!